Sample-level consent management is a critical component of clinical trials, especially follow-on and translational research. Best practice recommendations suggest that sponsors should use a configurable system to define a flexible and manageable set of attributes at the study, country, and site levels that can be applied to all samples collected over the duration of the trial.